Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u prethodnih 30 dana:46
  • preuzimanja u prethodnih 30 dana:38
članak: 1 od 1  
Medicinski časopis
2018, vol. 52, br. 1, str. 15-21
jezik rada: srpski
vrsta rada: pregledni članak
doi:10.5937/mckg52-16614


Značaj uloge vitamina D kod obolelih od multiple skleroze
Dom zdravlja Novi Sad, Novi Sad

e-adresa: suncicastankov@yahoo.com

Sažetak

Etiologija multiple skleroze i dalje je uglavnom nepoznata, ali brojni dokazi ukazuju na to da postoji interakcija između genetskih faktora i faktora spoljašnje sredine koji utiču na povećanje rizika za nastanak multiple skleroze. Faktori spoljašnje sredine za koje se smatra da učestvuju u patogenezi multiple skleroze uključuju Epstein-Barr virusnu infekciju, deficijenciju vitamina D i B12, kao i pušenje cigareta. Iako tačna etiologija multiple skleroze još nije determinisana, mnogi patofiziološki, eksperimentalni, epidemiološki, imunološki i biološki dokazi ukazuju na značaj uloge hipovitaminoze D kao jednog od najvažnijih spoljašnjih faktora u etiologiji multiple skleroze. Prevalencija multiple skleroze je veoma visoka u područjima sa niskim unosom D vitamina, a imunološke studije ukazuju na to da vitamin D ima modulirajući potencijal u odnosu na imuni sistem i značajnu ulogu u regulaciji homeostaze T limfocita. Osim dobro poznate osnovne uloge D vitamina u metabolizmu kostiju i homeostazi kalcijuma, vitamin D pokazuje i imunomodulatornu, anti-inflamatornu i potencijalnu neuroprotektivnu funkciju, što ukazuje na povoljno terapijsko dejstvo vitamina D u autoimunim bolestima kao što je multipla skleroza. Posebnu pažnju privlače savremena istraživanja koja pokazuju da lečenje deficijencije vitamina D može umanjiti invaliditet uzrokovan multiplom sklerozom. Prevencija bolesti i unapređenje zdravstvenog stanja obolelih od multiple skleroze mogući su kroz otkrivanje deficijencije vitamina D, njenu korekciju i adekvatnu upotrebu suplemenata, što značajno može uticati na poboljšanje kvaliteta života i zdravstvenog statusa osoba obolelih od multiple skleroze.

Ključne reči

Reference

Ascherio, A., Munger, K.L. (2007) Environmental risk factors for multiple sclerosis. Part I: The role of infection. Annals of Neurology, 61(4): 288-299
Ashtari, F., Ajalli, M., Shaygannejad, V., Akbari, M., Hovsepian, S. (2013) The relation between vitamin D status with fatigue and depressive symptoms of multiple sclerosis. J Res Med Sci, 18: 193-7
Bazelier, M.T., van Staa, T., Uitdehaag, B.M., Cooper, C., Leufkens, H.G., Vestergaard, P., Bentzen, J., de Vries, F. (2011) The risk of fracture in patients with multiple sclerosis: The UK general practice research. Journal of Bone and Mineral Research, 26(9): 2271-2279
Bendik, I., Friedel, A., Roos, F.F., Weber, P., Eggersdorfer, M. (2014) Vitamin D: a critical and essential micronutrient for human health. Frontiers in Physiology, 5: 248
Bikle, Daniel D. (2014) Vitamin D Metabolism, Mechanism of Action, and Clinical Applications. Chemistry & Biology, 21(3): 319-329
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., Carmeliet, G. (2016) Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiological Reviews, 96(1): 365-408
Dalmay, F., Bhalla, D., Nicoletti, A., Cabrera-Gomez, J., Cabre, P., Ruiz, F., Druet-Cabanac, M., Dumas, M., Preux, P. (2010) Multiple sclerosis and solar exposure before the age of 15 years: case-control study in Cuba, Martinique and Sicily. Multiple Sclerosis Journal, 16(8): 899-908
Darwish, H., Haddad, R., Osman, S., Ghassan, S., Yamout, B., Tamim, H., Khoury, S. (2017) Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients. Scientific Reports, 7(1):
Didonna, A., Oksenberg, J.R. (2015) Genetic determinants of risk and progression in multiple sclerosis. Clinica Chimica Acta, 449: 16-22
Döring, A., Paul, F., Dörr, J. (2013) Vitamin D and multiple sclerosis. Der Nervenarzt, 84(2): 173-189
Dörr, J., Döring, A., Paul, F. (2013) Can we prevent or treat multiple sclerosis by individualised vitamin D supply?. EPMA Journal, 4(1):
Ghasemi, N., Razavi, S., Nikzad, E. (2017) Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J, 19: 1-10
Harandi, A.A., Harandi, A.A., Pakdaman, H., Sahraian, M.A. (2014) Vitamin D and multiple sclerosis. Iran J Neurol, 13: 1-6
Huang, W., Chen, W., Zhang, X. (2017) Multiple sclerosis: Pathology, diagnosis and treatments. Experimental and Therapeutic Medicine, 13(6): 3163-3166
Islam, T., Gauderman, W.J., Cozen, W., Mack, T.M. (2007) Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology, 69(4): 381-388
Kampman, M.T., Wilsgaard, T., Mellgren, S.I. (2007) Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. Journal of Neurology, 254(4): 471-477
Kfoczyńska, M., Kucharska, A., Sińska, B. (2015) The role of vitamin D in multiple sclerosis. Postępy Higieny i Medycyny Doświadczalnej, 69: 440-446
Landel, V., Annweiler, C., Millet, P., Morello, M., Féron, F. (2016) Vitamin D, Cognition and Alzheimer’s Disease: The Therapeutic Benefit is in the D-Tails. Journal of Alzheimer's Disease, 53(2): 419-444
Libbey, J.E., Cusick, M.F., Fujinami, R.S. (2014) Role of Pathogens in Multiple Sclerosis. International Reviews of Immunology, 33(4): 266-283
McDowell, T., Amr, S., Culpepper, W.J., Langenberg, P., Royal, W., Bever, C., Bradham, D.D. (2011) Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis. Neuroepidemiology, 36(1): 39-45
Mosayebi, G., Ghazavi, A., Ghasami, K., Jand, Y., Kokhaei, P. (2011) Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients. Immunological Investigations, 40(6): 627-639
Mulcahy, K.B., Trigoboff, E., Opler, L., Demler, T.L. (2016) Physician prescribing practices of vitamin D in a psychiatric hospital. Innov Clin Neurosci, 13: 21-7
Nair, R., Maseeh, A. (2012) Vitamin D: the sunshine vitamin. J Pharmacol Pharmacother, 3: 118-26
Namjooyan, F., Ghanavati, R., Majdinasab, N., Jokari, S., Janbozorgi, M. (2014) Uses of Complementary and Alternative Medicine in Multiple Sclerosis. Journal of Traditional and Complementary Medicine, 4(3): 145-152
Nessler, S., Brück, W. (2010) Advances in multiple sclerosis research in 2009. Journal of Neurology, 257(9): 1590-1593
Pierrot-Deseilligny, C. (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. Journal of Neurology, 256(9): 1468-1479
Pierrot-Deseilligny, C., Souberbielle, J. (2017) Vitamin D and multiple sclerosis: An update. Multiple Sclerosis and Related Disorders, 14: 35-45
Pludowski, P., Holick, M.F., Pilz, S., Wagner, C.L., Hollis, B.W., Grant, W.B., Shoenfeld, Y., Lerchbaum, E., Llewellyn, D.J., Kienreich, K., Soni, M. (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmunity Reviews, 12(10): 976-989
Schwalfenberg, G. (2007) Not enough vitamin D: health consequences for Canadians. Can Fam Physician, 53: 841-54
Shahbeigi, S., Pakdaman, H., Fereshtehnejad, S.M., Nikravesh, E., Mirabi, N., Jalilzadeh, G. (2013) Vitamin D3 concentration correlates with the severity of multiple sclerosis. Int J Prev Med, 4: 585-91
Shaygannejad, V., Golabchi, K., Haghighi, S., Dehghan, H., Moshayedi, A. (2010) A comparative study of 25 (OH) vitamin D serum levels in patients with multiple sclerosis and control group in Isfahan, Iran. Int J Prev Med, 1: 195-201
Shaygannejad, V., Janghorbani, M., Ashtari, F., Dehghan, H. (2012) Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial. Multiple Sclerosis International, 2012: 1-7
Smolders, J. (2011) Vitamin D and Multiple Sclerosis: Correlation, Causality, and Controversy. Autoimmune Diseases, 2011: 1-3
Soilu-Hänninen, M., Åivo, J., Lindström, B., Elovaara, I., Sumelahti, M., Färkkilä, M., Tienari, P., Atula, S., Sarasoja, T., Herrala, L., Keskinarkaus, I., Kruger, J., Kallio, T., Rocca, M.A., Fili (2012) A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 83(5): 565-571
Speer, G. (2013) Impact of vitamin D in neurological diseases and neurorehabilitation: from dementia to multiple sclerosis. Part I: the role of vitamin D in the prevention and treatment of multiple sclerosis. Ideggyogy Sz, 66: 293-303 [Article in Hungarian]
Stein, M.S., Liu, Y., Gray, O.M., Baker, J.E., Kolbe, S.C., Ditchfield, M.R., Egan, G.F., Mitchell, P.J., Harrison, L.C., Butzkueven, H., Kilpatrick, T.J. (2011) A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology, 77(17): 1611-1618
van der Schaft, J., Koek, H.L., Dijkstra, E., Verhaar, H.J.J., van der Schouw, Y.T., Emmelot-Vonk, M.H. (2013) The association between vitamin D and cognition: A systematic review. Ageing Research Reviews, 12(4): 1013-1023
Wang, H., Chen, W., Li, D., Yin, X., Zhang, X., Olsen, N., Zheng, S.G. (2017) Vitamin D and Chronic Diseases. Aging and Disease, 8(3): 346
Yadav, V., Shinto, L., Bourdette, D. (2010) Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Review of Clinical Immunology, 6(3): 381-395
Zuvich, R.L., McCauley, J.L., Pericak-Vance, M.A., Haines, J.L. (2009) Genetics and pathogenesis of multiple sclerosis. Seminars in Immunology, 21(6): 328-333